A medicament for treating candidal vulvovaginitis in a birth control room

Abstract

The invention relates to a medicament for treating candidal vulvovaginitis in a birth control room. The medicament is prepared from following compounds by weight: 10-20 parts of psychotria calocarpa kurz, 5-15 parts of common calanthe herb, 10-20 parts of dwarf sheareria herb, 10-20 parts of pittosporum daphniphylloides hayata, 1-10 parts of semen iridis chinensis, 20-30 parts of oriental dodartia herb, 1-10 parts of tetragonal crotalaria herb, 5-15 parts of ceylon persimmon sawdust, 10-20 parts of largeleaf tea, 1-10 parts of myricaria bracteata royle, 20-30 parts of negundo chastetree leaf, 10-20 parts of nanocnide pilosa migo, 5-15 parts of ardisia brevicaulis diels, 10-20 parts of siebold knotweed fruit or herb, 20-30 parts of cuneate lespedeza herb with root, 5-15 parts of glabrous crazyweed herb, 5-15 parts of pansy, 20-30 parts of Indian pentanema herb, 5-15 parts of asiatic bilberry and 1-10 parts of licorice. The medicament has obvious curative effects for treating the candidal vulvovaginitis, and is simple and convenient in operation, safe to use, low in side and toxic effects, prone to popularization in clinic, and easily accepted by patients.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicament for treating vulvovaginal candidiasis in a family planning room. Background technique [0002] Vulvovaginal candidiasis is a common and frequently-occurring disease in women of childbearing age. 75% of women have at least one vaginal candida infection in their lifetime, and about 5% of patients relapse after treatment. The most common symptoms of infection are excessive leucorrhea with bean dregs-like appearance, burning and itching of vulva and vagina, dysuria, and geographic erythema of vulva. In severe cases, ecchymosis may remain and often recur, which has a significant impact on the health and quality of life of patients. [0003] Modern medicine mainly treats Candida, and external treatment is still the main method and means in clinical practice at present, such as the application of antifungal drugs Dactin, fluconazole, and ketoconazole. Antifungal drugs have a stron...

AI Technical Summary

Problems solved by technology

Antifungal drugs have a strong purpose and have played a huge role in clinical treatment. They are indeed effective for some cases that did not develop resistance at the beginning of the disease, but with the emergence of drug resistance, the therapeutic effect gradually decreases, leading to continuous recurrence

Images